A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
Clinical trial NCT03954106 · TERMINATED
Trial details
- NCT number
- NCT03954106
- Sponsor
- Jazz Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2020-09-18
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.